Información de la publicación

Portal del Investigador > Publicaciones > detalle publicacion

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): a randomised, pragmatic trial

Otras comunicaciones del congreso o articulos relacionados con autores/as de la Universidad de Cantabria

A phase III randomized controlled trial of plitidepsin, a marine-derived compound, in hospitalized adults with moderate COVID-19 (NEPTUNO) - Comunicación a Congreso
The nasopharyngeal microbiome in COVID-19 infection - Comunicación a Congreso
Predictors of in-hospital mortality in coagulase-negative staphylococci bacteraemia: findings from a Spanish multi-centre cohort - Comunicación a Congreso
Clinical characteristics and predisposing risk factors for Enterococcus faecalis and Enterococcus faecium bloodstream infections: a prospective multi-centre cohort study from the PROBAC projec - Comunicación a Congreso
Characteristics and prognosis of patients following complete surgical removal of infected vascular graft - Comunicación a Congreso
Outcomes and factors associated with mortality for Enterococcus faecalis and Enterococcus faecium bloodstream infections: a prospective multi-centre cohort study from the PROBAC project - Comunicación a Congreso
Development and internal validation of a simplified scoring model with CURB-65 plus RNAemia for predicting mortality at diagnosis of SARS-CoV-2 pneumonia - Comunicación a Congreso
Factors associated with the development of SARS-CoV-2 RNAemia at COVID-19 diagnosis - Comunicación a Congreso
Safety and efficacy of long-acting HIV treatment in real life at a tertiary care hospital - Comunicación a Congreso
Profile of patients treated with fidaxomicin in a tertiary hospital - Comunicación a Congreso
Bacteraemias of unknown origin: description and prognostic analysis - Comunicación a Congreso
Definition of early prosthetic valve endocarditis - Comunicación a Congreso

Congreso: Congress of the European Society of Clinical Microbiology and Infectious Diseases (35º : 2025 : Viena)

Editorial: Elsevier

Año de publicación: 2025

Nº de páginas: 2

Tipo de publicación: Comunicación a Congreso

ISSN: 2950-5909

Url de la publicación: https://www.cmi-comms.org/article/S2950-5909(25)00027-7/pdf

Autoría

COGLIATI DEZZA, F.

BARRERA PULIDO, L.

BORREGERO BORREGUERO, I.

DOCOBO PÉREZ, F.

PALOMO JIMÉNEZ, V.

ROSA RIESTRA, D. DE LA

BRAVO-FERRER ACOSTA, J.

LÓPEZ ZÚÑIGA, M. A.

COBO, F.

GOMEZ-JUNYET, J.

HORCAJADA, J. P.

MERINO, E.

PARRA, M.

LÓPEZ-CONTRERAS, J.

RIVERA, A.

SOUSA REGUEIRO, D.

PAMPÍN GARCÍA, M.

LÓPEZ CÁRDENAS, S.

MARIA DEL CARMEN FARIÑAS ALVAREZ

Descargar referencia

Bib Ris

Volver

Researchers portal

Portal del personal investigador

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): a randomised, pragmatic trial

Autoría

Descargar referencia